TAR Patients
| Patient No. . | Sex . | Absent Radii . | Requirement of Platelet Transfusions . | Age . | WBC (μL−1) . | Hgb (g/dL) . | Plt (μL−1) . | Tests Performed* . |
|---|---|---|---|---|---|---|---|---|
| 1 | F | + | + | 2 yr 6 mo | 8,100 | 11.7 | 57,000 | 1, 2, 3, 4, 5 |
| 3 yr 7 mo | 6,700 | 12.1 | 87,000 | 3, 6 | ||||
| 2 | F | + | + | 1 yr 11 mo | 15,000 | 8.6 | 28,000 | 1, 3, 4, 5 |
| 2 yr 9 mo | ND | ND | 31,000 | 1, 2, 3, 4, 6 | ||||
| 3 | M | + | + | 6 wk | 10,800 | 8.0 | 25,000 | 1, 5 |
| 10 mo | 11,900 | 13.6 | 72,000 | 1, 2, 3, 4, 6 | ||||
| 4 | F | + | − | 6 d | ND | ND | ND | 7 |
| 6 mo | 27,000 | 8.7 | 10,000 | 1, 2, 3, 5 | ||||
| 5† | F | + | + | 6 yr 11 mo | 12,000 | 10.7 | 12,000 | 1, 2, 6 |
| 7 yr 8 mo | 8,400 | 8.4 | 12,000 | 1, 2, 3, 4, 5 |
| Patient No. . | Sex . | Absent Radii . | Requirement of Platelet Transfusions . | Age . | WBC (μL−1) . | Hgb (g/dL) . | Plt (μL−1) . | Tests Performed* . |
|---|---|---|---|---|---|---|---|---|
| 1 | F | + | + | 2 yr 6 mo | 8,100 | 11.7 | 57,000 | 1, 2, 3, 4, 5 |
| 3 yr 7 mo | 6,700 | 12.1 | 87,000 | 3, 6 | ||||
| 2 | F | + | + | 1 yr 11 mo | 15,000 | 8.6 | 28,000 | 1, 3, 4, 5 |
| 2 yr 9 mo | ND | ND | 31,000 | 1, 2, 3, 4, 6 | ||||
| 3 | M | + | + | 6 wk | 10,800 | 8.0 | 25,000 | 1, 5 |
| 10 mo | 11,900 | 13.6 | 72,000 | 1, 2, 3, 4, 6 | ||||
| 4 | F | + | − | 6 d | ND | ND | ND | 7 |
| 6 mo | 27,000 | 8.7 | 10,000 | 1, 2, 3, 5 | ||||
| 5† | F | + | + | 6 yr 11 mo | 12,000 | 10.7 | 12,000 | 1, 2, 6 |
| 7 yr 8 mo | 8,400 | 8.4 | 12,000 | 1, 2, 3, 4, 5 |
Abbreviations: WBC, white blood count; Hgb, Hemoglobin; Plt, platelets; ND, not determined.
Code for the different examinations: 1, TPO serum level; 2, IL-11, IL-6, LIF level; 3, c-Mpl (flow cytometry); 4, c-Mpl (Western-blotting); 5, TPO reactivity (flow cytometry); 6, TPO reactivity (Tyrosine phosphorylation); 7, CFU-mega.
This patient has been described in an earlier abstract.6